/PRNewswire/ CTI BioPharma Corp. (NASDAQ: CTIC) today announced the grant of equity awards to two new employees as equity inducement awards outside of the.
/PRNewswire/ CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors.
/PRNewswire/ CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the second quarter ended June 30, 2022. "CTI continues to make.
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) CFO David Kirske sold 60,000 shares of the firm’s stock in a transaction dated Friday, June 17th. The stock was sold at an average price of $6.21, for a total transaction of $372,600.00. Following the completion of the transaction, the chief financial officer now directly owns 7,397 shares […]
/PRNewswire/ CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors.